封面
市場調查報告書
商品編碼
1390563

胎牛血清市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Fetal Bovine Serum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年,全球胎牛血清市場規模達到9.48億美元。展望未來, IMARC Group預計到2028年市場規模將達到13.333億美元,2022-2028年複合年成長率(CAGR)為5.85%。

胎牛血清(FBS)是動物細胞培養基的主要成分,從牛的牛胎兒中獲得。它含有多種細胞生長必需的營養和大分子因子。除此之外,它還含有胺基酸、糖、脂質、荷爾蒙和低丙種球蛋白含量。因此,它被廣泛用於一系列應用,例如提供必需營養素並促進真核細胞培養中的細胞存活和增殖。它也用於研究、製造、生物技術藥物以及控制人用和獸用疫苗。

胎牛血清市場趨勢:

FBS 可用於產生幹細胞,用於治療因冠狀病毒疾病 (COVID-19) 引起的急性和慢性肺損傷的患者。此外,由於它含有生長因子和抗體,可在實驗室中利用以保持細胞存活以進行分裂、生長和進化,因此它在各種科學研究中發揮關鍵作用。再加上政府和私人機構為引進新型生物製藥提供的資金增加,研發 (R&D) 活動顯著成長,正在刺激全球對胎牛血清的需求。此外,由於急性和慢性疾病的日益流行,對生物製藥產品的需求不斷增加,也促進了市場的成長。除此之外,核心家庭的新興趨勢和不斷上漲的收入水準正在積極影響寵物的擁有和人性化,從而導致全球擴大採用伴侶動物。隨著動物性產品消費量的不斷增加,預計將推動世界各地獸醫診斷和疫苗中對胎牛血清的需求,以預防傳染病。

本報告回答的關鍵問題

  • 2022年全球胎牛血清市場規模有多大?
  • 2023-2028年全球胎牛血清市場的預期成長率是多少?
  • COVID-19對全球胎牛血清市場有何影響?
  • 推動全球胎牛血清市場的關鍵因素是什麼?
  • 基於該產品的全球胎牛血清市場的細分如何?
  • 基於應用的全球胎牛血清市場的細分如何?
  • 基於最終用戶的全球胎牛血清市場的細分如何?
  • 全球胎牛血清市場的重點區域有哪些?
  • 全球胎牛血清市場的主要參與者/公司有哪些?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球胎牛血清市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:按產品分類的市場區隔

  • 木炭剝離
    • 市場走向
    • 市場預測
  • 色譜法
    • 市場走向
    • 市場預測
  • 透析胎牛血清
    • 市場走向
    • 市場預測
  • 外泌體耗盡
    • 市場走向
    • 市場預測
  • 幹細胞
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章:按應用分類的市場區隔

  • 生物製藥
    • 市場走向
    • 市場預測
  • 細胞培養
    • 市場走向
    • 市場預測
  • 人類和動物疫苗生產
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章:最終用戶的市場區隔

  • 生物技術和製藥公司
    • 市場走向
    • 市場預測
  • 學術機構
    • 市場走向
    • 市場預測
  • 研究實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

第14章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Atlas Biologicals Inc.
    • Biological Industries (Sartorius AG)
    • Bio-Techne Corporation
    • BioWest
    • Bovogen Biologicals Pty Ltd.
    • General Electric Company
    • HiMedia Laboratories
    • Merck KGaA
    • PAN-Biotech
    • Rocky Mountain Biologicals
    • TCS Biosciences Ltd
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4345

Abstract

The global fetal bovine serum market size reached US$ 948.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,333.3 Million by 2028, exhibiting a growth rate (CAGR) of 5.85% during 2022-2028.

Fetal bovine serum (FBS) is a major component of animal cell culture media, which is obtained from bovine fetuses of cows. It has several nutritional and macromolecular factors that are essential for cell growth. Besides this, it also comprises amino acids, sugars, lipids, hormones, and low gamma globulin content. As a result, it is widely utilized in a range of applications, such as providing essential nutrients and facilitating cell survival and proliferation in eukaryotic cell culture. It is also used in research, manufacturing, biotech drugs, and controlling human and veterinary vaccines.

Fetal Bovine Serum Market Trends:

FBS finds application in generating stem cells for treating patients suffering from acute and chronic lung damage due to coronavirus disease (COVID-19). In addition, as it contains growth factors and antibodies that can be utilized in laboratories to keep cells alive for dividing, growing, and evolving, it plays a pivotal role in various scientific research. This, along with significant growth in the research and development (R&D) activities on account of increasing funding by governing and private agencies to introduce novel biopharmaceuticals, is catalyzing the demand for FBS worldwide. Furthermore, the escalating demand for biopharma products on account of the growing prevalence of acute and chronic diseases is contributing to the growth of the market. Apart from this, the emerging trend of nuclear families and inflating income levels are positively influencing pet ownership and humanization, which is resulting in the increasing adoption of companion animals across the globe. This, along with the rising consumption of animal-derived products, is anticipated to fuel the need for FBS in veterinary diagnostics and vaccines to prevent infectious diseases around the world.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global fetal bovine serum market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Charcoal Stripped

Chromatographic

Dialyzed Fetal Bovine Serum

Exosome Depleted

Stem Cell

Others

Breakup by Application:

Biopharmaceuticals

Cell Culture

Human and Animal Vaccine Production

Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies

Academic Institutes

Research Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Atlas Biologicals Inc., Biological Industries (Sartorius AG), Bio-Techne Corporation, BioWest, Bovogen Biologicals Pty Ltd., General Electric Company, HiMedia Laboratories, Merck KGaA, PAN-Biotech, Rocky Mountain Biologicals, TCS Biosciences Ltd and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global fetal bovine serum market in 2022?
  • 2. What is the expected growth rate of the global fetal bovine serum market during 2023-2028?
  • 3. What has been the impact of COVID-19 on the global fetal bovine serum market?
  • 4. What are the key factors driving the global fetal bovine serum market?
  • 5. What is the breakup of the global fetal bovine serum market based on the product?
  • 6. What is the breakup of the global fetal bovine serum market based on the application?
  • 7. What is the breakup of the global fetal bovine serum market based on the end user?
  • 8. What are the key regions in the global fetal bovine serum market?
  • 9. Who are the key players/companies in the global fetal bovine serum market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fetal Bovine Serum Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Charcoal Stripped
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chromatographic
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dialyzed Fetal Bovine Serum
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Exosome Depleted
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Stem Cell
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biopharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cell Culture
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Human and Animal Vaccine Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Biotechnology and Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Atlas Biologicals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Biological Industries (Sartorius AG)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-Techne Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 BioWest
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bovogen Biologicals Pty Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 HiMedia Laboratories
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 PAN-Biotech
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rocky Mountain Biologicals
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 TCS Biosciences Ltd
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Fetal Bovine Serum Market: Major Drivers and Challenges
  • Figure 2: Global: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Fetal Bovine Serum Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Fetal Bovine Serum Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Fetal Bovine Serum Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Fetal Bovine Serum Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Fetal Bovine Serum (Charcoal Stripped) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Fetal Bovine Serum (Charcoal Stripped) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Fetal Bovine Serum (Chromatographic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Fetal Bovine Serum (Chromatographic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Fetal Bovine Serum (Dialyzed Fetal Bovine Serum) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Fetal Bovine Serum (Exosome Depleted) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Fetal Bovine Serum (Exosome Depleted) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Fetal Bovine Serum (Stem Cell) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Fetal Bovine Serum (Stem Cell) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Fetal Bovine Serum (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Fetal Bovine Serum (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Fetal Bovine Serum (Biopharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Fetal Bovine Serum (Biopharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Fetal Bovine Serum (Cell Culture) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Fetal Bovine Serum (Cell Culture) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Fetal Bovine Serum (Human and Animal Vaccine Production) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Fetal Bovine Serum (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Fetal Bovine Serum (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Fetal Bovine Serum (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Fetal Bovine Serum (Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Fetal Bovine Serum (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Fetal Bovine Serum (Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Fetal Bovine Serum (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Fetal Bovine Serum (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Fetal Bovine Serum (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Fetal Bovine Serum Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Fetal Bovine Serum Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Fetal Bovine Serum Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Fetal Bovine Serum Industry: SWOT Analysis
  • Figure 86: Global: Fetal Bovine Serum Industry: Value Chain Analysis
  • Figure 87: Global: Fetal Bovine Serum Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fetal Bovine Serum Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Fetal Bovine Serum Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Fetal Bovine Serum Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Fetal Bovine Serum Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Fetal Bovine Serum Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Fetal Bovine Serum Market: Competitive Structure
  • Table 7: Global: Fetal Bovine Serum Market: Key Players